PMV Pharmaceuticals
Présence
PMV Pharmaceuticals fait partie des...
PMV Pharmaceuticals est une société cotée sous le symbole boursier PMVP (US).
Dirigeants
Voir l'organigramme avec ses 19 principaux dirigeants
Biographies les plus recherchées chez PMV Pharmaceuticals
- David Mack, Director, President and Chief Executive Officer
- Arnold Levine, Director
- Kirsten Flowers, Director
Changements de dirigeants chez PMV Pharmaceuticals
- Leila Alland, Chief Medical Officer, a quitté l'entreprise (publié le 21 janvier 2024).
- Winston Kung, Chief Operating Officer and Chief Financial Officer, a quitté l'entreprise (publié le 8 janvier 2024).
- Michael Carulli qui était Senior Vice President, Finance, est promu Chief Financial Officer (publié le 8 janvier 2024).
Créer une alerte
pour suivre les mouvements de dirigeants chez PMV Pharmaceuticals.
Pharmacie
PMV Pharmaceuticals a 1 861 concurrents dont Pfizer (Etats—Unis), Sanofi (France) et Johnson & Johnson (Etats—Unis).
Actualités en fusion/acquisition en Pharmacie.
- MedMen has filed for bankruptcy protection (publié le 28 avril 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (publié le 23 mars 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publié le 19 mars 2024).
Contacts en Pharmacie
Actualités
Derniers communiqués de presse par PMV Pharmaceuticals
- PMV Pharmaceuticals Announces a Clinical Trial Collaboration with Merck to Evaluate PC14586 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Solid Tumors | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals to Participate in the Goldman Sachs Global Healthcare Conference | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals Initial PC14586 Phase 1 Data Presented at ASCO Demonstrated Anti-Tumor Activity Across Multiple Solid Tumor Types With a p53 Y220C Mutation | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals Announces Initial PC14586 Phase 1 Clinical Data to be Presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals Reports First Quarter 2022 Financial Results and Corporate Highlights | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals to Present PC14586 Phase 1 Clinical Data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals to Participate in the 42nd Annual Cowen Health Care Conference | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals to Participate in the Guggenheim Healthcare Talks 2022 Oncology Day | PMV Pharmaceuticals, Inc.
- PMV Pharma Announces Changes to its Board of Directors | PMV Pharmaceuticals, Inc.
- Voir plus de communiqués de presse Close
Réseaux sociaux à propos de PMV Pharmaceuticals
- PMV Pharmaceuticals sur Wikipédia, Google News & Yahoo Finance en 1-click
- PMV Pharmaceuticals sur LinkedIn, Twitter & YouTube en 1-click
Entrer en contact
Contacter par email ses dirigeants dont David Mack 
Appelez PMV Pharmaceuticals au +1 609...
